Sort   by:  
 Page size 
TranscriptomicsTranscription profiling by array of human circulating endothelial cells before and after Iloprost infusion in patients with progressive Systemic sclerosis.
Gene expression profiling in circulating endothelial cells before and after Iloprost infusion in patients with progressive Systemic sclerosis.
ORGANISM(S): Homo sapiens 
2010-06-28 | E-MEXP-2769 | biostudies-arrayexpress
TranscriptomicsPhase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment response biomarker assessment (scRNA-Seq).
Iloprost, a prostacyclin analog, has lung cancer preventive activity in preclinical models and improved dysplasia in former smokers in a phase IIb trial. Oral iloprost is currently unavailable.We performed a phase Ib trial of inhaled iloprost in former smokers to assess tolerance and compliance. Par...
ORGANISM(S): Homo sapiens 
2023-09-21 | GSE240001 | GEO
TranscriptomicsPhase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment response biomarker assessment (Bulk RNA-Seq).
Iloprost, a prostacyclin analog, has lung cancer preventive activity in preclinical models and improved dysplasia in former smokers in a phase IIb trial. Oral iloprost is currently unavailable.We performed a phase Ib trial of inhaled iloprost in former smokers to assess tolerance and compliance. Par...
ORGANISM(S): Homo sapiens 
2023-09-21 | GSE240000 | GEO
GenomicsPhase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment response biomarker assessment (scRNA-Seq).
Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment response biomarker assessment (scRNA-Seq).
PRJNA1001898 | ENA
GenomicsPhase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment response biomarker assessment (Bulk RNA-Seq).
Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment response biomarker assessment (Bulk RNA-Seq).
PRJNA1001899 | ENA
ProteomicsImpaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS
Patients diagnosed with pseudohypoparathyroidism type Ia (PHP Ia) suffer from hormonal resistance. This is often accompanied by abnormal postural and facial features, brachydactyly and dermal calcifications, a condition classified as Albright hereditary osteodystrophy (AHO) syndrome. Typically, this...
ORGANISM(S): Homo sapiens (Human) 
2021-09-08 | PXD016534 | Pride
Human platelets Phosphoproteome Tmt Itraq Proteome Albright hereditary osteodystrophy 
UnknownIntranasal Iloprost Prevents Tumors in a Murine Lung Carcinogenesis Model.
Not available
S-EPMC8966202 | biostudies-literature
UnknownLiposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries.
Not available
S-EPMC4094575 | biostudies-literature
UnknownIloprost requires the Frizzled-9 receptor to prevent lung cancer.
Not available
S-EPMC9189122 | biostudies-literature
UnknownIloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury.
Not available
S-EPMC3661223 | biostudies-literature
Sort   by:  
 Page size